All Stories

  1. The association between 25(OH)D levels, frailty status and obesity indices in older adults
  2. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning?
  3. Psychopathological dimensions in subjects with hereditary ATTR V30M amyloidosis and their relation with life events due to the disease
  4. Life paths of patients with transthyretin-related familial amyloid polyneuropathy Val30Met: a descriptive study
  5. ESPEN diagnostic criteria for malnutrition – A validation study in hospitalized patients
  6. Impact on mid-term kidney graft outcomes of pretransplant anti-HLA antibodies detected by solid-phase assays: Do donor-specific antibodies tell the whole story?
  7. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study
  8. End-stage renal disease versus death in a Portuguese cohort of elderly patients: an approach using competing event analysis
  9. Comparison of Jamar and Bodygrip Dynamometers for Handgrip Strength Measurement
  10. Triceps skinfold compressibility in hospitalized patients
  11. Incorporating Scoring Risk Models for Care Planning of the Elderly with Chronic Kidney Disease
  12. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation
  13. Effects of Posture and Body Mass Index on Body Girth Assessment
  14. Financial impact of sarcopenia on hospitalization costs
  15. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments
  16. Sarcopenia and length of hospital stay
  17. Sarcopenia among hospitalized patients – A cross-sectional study
  18. A triple-biomarker approach for the detection of delayed graft function after kidney transplantation using serum creatinine, cystatin C, and malondialdehyde
  19. Impact ofde novodonor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas-kidney transplantation
  20. Usefulness of Six Diagnostic and Screening Measures for Undernutrition in Predicting Length of Hospital Stay: A Comparative Analysis
  21. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation
  22. The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis
  23. Leptin and Adiponectin During the First Week After Kidney Transplantation: Biomarkers of Graft Dysfunction?
  24. Health-related quality of life may improve after transplantation in pancreas-kidney recipients
  25. Familial Amyloid Polyneuropathy treatment with Tafamidis – evaluation of one- and two-year treatment in Porto, Portugal
  26. Comparative analysis of undernutrition screening and diagnostic tools as predictors of hospitalisation costs
  27. Handgrip strength measurement as a predictor of hospitalization costs
  28. Adipokines in Peritoneal Dialysis: Relevant Clinical Impact According to Body Composition
  29. Handgrip strength cutoff values for undernutrition screening at hospital admission
  30. Oxidative Stress in Kidney Transplantation
  31. Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter?
  32. Posttransplant Allosensitization in Low Immunological Risk Kidney and Kidney-Pancreas Graft Recipients
  33. Handgrip Strength and Associated Factors in Hospitalized Patients
  34. Hand length as an alternative measurement of height
  35. Kidney Transplantation in Type 2 Diabetic Patients: A Matched Survival Analysis
  36. Cardiovascular Risk Factors and Events in Pancreas-Kidney Transplants
  37. Noncutaneous Neoplasms After Kidney Transplantation: Analysis at Single Center
  38. Pregnancy After Kidney Transplantation: Graft, Mother, and Newborn Complications
  39. A Comparison Between Serum Creatinine and Cystatin C-Based Equations for Estimation of Graft Function
  40. Advantages of Kidney Transplant Precocity in Graft Long-Term Survival
  41. Hyperuricemia in Adult Renal Allograft Recipients: Prevalence and Predictors
  42. Over Ten-Year Kidney Graft Survival Determinants
  43. First-Year Renal Function Predicts Long-Term Renal Allograft Loss
  44. Impact of Pediatric Kidney Transplantation on Long-Term Professional and Social Outcomes
  45. Steroid Withdrawal in Simultaneous Pancreas-Kidney Transplantation: A 7-Year Report
  46. Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M
  47. Impact Assessment in Living Kidney Donation: Psychosocial Aspects in the Donor
  48. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M
  49. Low Erythropoietin Production in Familial Amyloidosis TTR V30M Is Not Related with Renal Congophilic Amyloid Deposition
  50. The Influence of HLA Mismatches and Immunosuppression on Kidney Graft Survival: An Analysis of More Than 1300 Patients
  51. Peritoneal Membrane Evaluation in Routine Clinical Practice
  52. Liver transplantation and anemia in familial amyloidosis ATTR V30M
  53. Impact of Hepatitis C Virus on Renal Transplantation: Association With Poor Survival
  54. Renal Transplantation in Patients Over 60 Years of Age: A Single-Center Experience
  55. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation
  56. Immunosuppression With Antithymocyte Globulin in Renal Transplantation: Better Long-Term Graft Survival
  57. Impact of Homocysteinemia on Long-Term Renal Transplant Survival
  58. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry
  59. Kidney and anemia in familial amyloidosis type I
  60. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors
  61. Kinetic modeling studies of ethylene polymerization reactions using supported chromium catalysts
  62. Homocysteine levels in pediatric renal transplant recipients
  63. Lipoprotein(A) in renal transplant recipients
  64. Hyperhomocysteinemia in renal transplantation: preliminary results
  65. Therapy of post-renal transplantation hyperlipidaemia: comparative study with simvastatin and fish oil